Skip navigation.

Stakeholder Consultation on Priority Implementation Reasearch to Inform Dvelopment of WHO Normative Guidance on Pre-Exposure Prophylaxis, 26-28 March 2014, Durban, South Africa

Publication year: 
Corporate author: 
Publication details: 
Geneva, WHO, 2015

WHO’s Department of Reproductive Health and Research (RHR) and the Centre for the AIDS programme of research in South Africa (CAPRISA) convened a stakeholder consultation to identify priority implementation research on tenofovir gel and dapivirine ring to inform development of WHO normative guidelines on use of topical pre-exposure prophylaxis (PrEP). The Stakeholder Consultation brought together researchers, policymakers, programme managers, NGOs, donors, representatives of industry and other experts (see Appendix A). Through discussions informed by a series of technical presentations, the group worked to determine what issues were most critical for development of WHO guidelines, and the research approaches and timing where they can be addressed.

Based on a series of presentations, debate and discussions, participants worked to identify and prioritize issues in programme implementation of tenofovir gel and dapivirine ring and to determine what could be addressed in each of three phases of research.

This report summarizes the presentations and rich discussions, and concludes with a section on recommendations and next steps. The structure of the report follows the meeting agenda (Appendix B) although in a few cases discussions on similar topics have been combined.